A start-up born thanks to a joint venture between the highly specialized expertise of Italian technicians and designers and a Swiss company that is a world leader in the design and production of isolators (SKAN AG), Pharma Integration has the main objective of designing and developing next-generation systems for the distribution of fully robotized (with no compromises) injectable products integrated in next-generation isolators. The services, technology and production model will be offered worldwide. The company, which took up residence in the TLS incubation spaces in July 2015, began the design and prototyping of the new units in 2016 and has a development plan that will lead, by 2020, to hiring approximately 45 staff members. The industrial model is based on the massive use of new graduates from regional universities, with the goal of becoming a reference center for the training of specialized technicians for the production, control and management of the plants.
Pharma Integration designs and integrates systems, instruments and data collection dedicated to injectable products and new drug generation using robots and isolator technology, introducing real innovation on the pharma equipment production chain. The services, technology and production model are offered worldwide.